We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Views of RNA Polymerase

By Biotechdaily staff writers
Posted on 10 Jun 2002
Three-dimensional images of the initiation steps of DNA transcription in bacteria have been obtained and are described in a pair of recently published articles. More...
The reports, which appear in the March 2002 issue of Molecular Cell and the May 17, 2002, issue of Science, illuminate how the process of transcription begins in bacteria and provide clues for future development of new antibacterial drugs.

RNA polymerases are among the largest and most complex proteins of living organisms. These holoenzymes are similar in overall structure in both prokaryotes and eukaryotes; each polymerase consists of two large polypeptide subunits and about six to 10 smaller ones. Typically the two largest polypeptides and a few of the smaller polypeptides form a core enzyme that is capable of transcribing essentially any DNA sequence, natural or artificial, into an RNA copy. The remaining smaller polypeptides restrict the transcribing capabilities of the enzyme to natural DNAs containing a promoter. The holoenzyme's sigma subunit ‘tells' RNAP where in the genomic DNA to start transcription. It does this by recognizing the promoter region and ‘melting' the DNA to expose one of the double-helical strands the RNAP will use as the template to synthesize RNA.

Investigators from Rockefeller University (New York NY, USA) used X-ray crystallography to study RNAP from the thermophilic bacterium Thermus aquaticus. As the crystals of bacterial RNAP produced did not allow high-resolution structural analysis, they developed an alternative hybrid approach. "From previous and parallel work in our lab, we had high resolution structures of the RNA polymerase and parts of the sigma subunit,” explained Dr. Seth Darst. "We fitted the high resolution structures into the lower resolution structure to obtain the structure of the holoenzyme. And since the structure of DNA is known, we used that to solve the structure of the holoenzyme bound to the promoter fragment.”

It is now clear that the sigma subunit contains four protein domains connected to one another by short stretches of amino acids called "linkers.” The domains of the sigma subunit spread out and bind to one face of the core enzyme, which positions sigma to bind to DNA. One of the linkers, containing about 33 amino acids, is much longer than the others. This linker goes inside the polymerase towards the active site and back out, producing a very unusual protein-protein interaction.
"These sigma domains sit on the surface of the RNA polymerase, but this very long linker is buried inside the polymerase, near the active site of the enzyme,” says Dr. Darst. "In order to establish this complex, there needs to be a lot of conformational changes to get the linker inside. The linker sticks inside the polymerase and actually blocks the path of the RNA. As the RNA transcript begins to be elongated, it has to push this linker out from a channel inside the polymerase. The linker's not completely pushed out until the RNA becomes about 12 nucleotides long.”

A transition occurs when the RNA transcript reaches a length of 12 nucleotides: the complex becomes much more stable and the elongation phase begins. "We think that signal to go into elongation occurs when the RNA becomes long enough to fill the channel,” says Darst. "It pushes the linker peptide out, and then sigma begins to fall off.”

A better understanding of transcription in bacteria could lead to new drug targets to treat bacterial infections, particularly those that are resistant to current antibiotics.



Related Links:
Rockefeller University

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Rheumatoid Factors (RF) Test
Rheumatoid Factors (RF)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.